Historical record - last NADAC effective date: 8/19/2020
Product Information
QC LORATADINE 10 MG TABLET is a generic product labeled by Chain Drug Marketing Association, priced at $0.0687 per EA under NDC 63868015130. Its NADAC has been published 354 times since Nov 28, 2013.
FDA first approved this application on Aug 18, 2003.
Strength
10 mg/1
Manufacturer
Chain Drug Marketing AssociationNDC
63868015130
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
8/19/2020
Active Ingredients
LORATADINEApproval Type
Generic (ANDA)
FDA Application
ANDA076134FDA Approved
8/18/2003
On Market Since
8/19/2003
Price Statistics
The NADAC for QC LORATADINE 10 MG TABLET has been published 354 times since Nov 28, 2013, and over the history we have for it it has risen 5.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0687 per EA |
|---|---|
| All-time high | $0.0770 (Feb 12, 2014) |
| All-time low | $0.0531 (Sep 21, 2016) |
| Median price | $0.0618 |
| Average price | $0.0628 |
| Largest weekly change | +26.8% (Mar 19, 2014) |
| Weeks tracked | 354 |
| Tracking since | Nov 28, 2013 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
N/A
5Y
N/A
All
+5.2%
Last surveyed Sep 2, 2020 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 17 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 23% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Chain Drug Marketing Association manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Loratadine market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of QC LORATADINE 10 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for QC LORATADINE 10 MG TABLET, manufactured by Chain Drug Marketing Association, is $0.0687 per EA (NDC 63868015130), effective Sep 2, 2020.
How has the price of QC LORATADINE 10 MG TABLET changed over time?
Over the history we have for it, the NADAC for QC LORATADINE 10 MG TABLET has risen 5.2%. It has been tracked across 354 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for QC LORATADINE 10 MG TABLET?
Since Nov 28, 2013, the NADAC for QC LORATADINE 10 MG TABLET has ranged from a low of $0.0531 (Sep 21, 2016) to a high of $0.0770 (Feb 12, 2014), with a median of $0.0618 per EA.
Are there cheaper alternatives to QC LORATADINE 10 MG TABLET?
Yes. 17 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, LORATADINE 10 MG TABLET, is $0.0529 per EA — about 23% below QC LORATADINE 10 MG TABLET.
Who manufactures QC LORATADINE 10 MG TABLET?
QC LORATADINE 10 MG TABLET (NDC 63868015130) is labeled by Chain Drug Marketing Association, and CMS classifies it as a generic product.